Aikman’s involvement marks a departure from his typical approach to endorsements, which he has historically avoided to maintain his reputation. He cited Qualia’s insistence on human clinical trials and peer-reviewed research—standards rarely prioritized by mainstream supplement brands—as the primary reason for his decision to take an equity stake. According to the former quarterback, his daily regimen has allowed him to sustain energy levels comparable to his younger years.
Founded in 2015, the Carlsbad-based company has recently gained traction through aggressive scientific validation, including a 2025 Nutrition Business Journal Science & Innovation Award and inclusion on the 2026 Inc. 5000 list. CEO James Schmachtenberger noted that Aikman’s commitment stems from a shared emphasis on rigorous testing protocols, which the company uses to differentiate its products in a crowded wellness market. As part of this expansion, Qualia has secured retail distribution across major chains such as GNC, Sprouts, and The Vitamin Shoppe, while preparing to launch additional formulas in the coming year.

Comments (0)
No comments yet. Be the first!